Navigation Links
CEM President and CEO Delivers Commencement Address at the University of Texas at Austin Chemistry and Biochemistry Department Graduation
Date:7/19/2011

MATTHEWS, N.C., July 19, 2011 /PRNewswire/ -- CEM Corporation president and CEO Michael J. Collins delivered the Commencement address for the University of Texas at Austin Chemistry and Biochemistry Department, which was held on May 20, 2011. Collins received his PhD in Physical Chemistry from the University and has been a member of the Advisory Board for the Chemistry Department at the school for a number of years.

(Logo:  http://photos.prnewswire.com/prnh/20090622/CL35336LOGO-b)

"I am honored to have been asked to deliver the Commencement address this year," said Michael J. Collins. "UT has one of the strongest chemistry and biochemistry programs in the country with very talented and promising students. It was wonderful to have the opportunity to share my experiences with them and I appreciate them sharing their special day with me."

Collins told the audience about his time at the University of Texas at Austin and how it helped shape his life. He drew comparisons between the economic outlook when he graduated and the world that today's graduates will be facing, predicting that the same economic trends that brought the prosperity of the past twenty-five years will again bring rapid economic growth in the next five years.

"Technology will continue to transform the world we live in and most of the transformational innovations will be chemistry and biochemistry based," said Collins. "All of you have chosen a great field of endeavor and your futures should be very bright."

Collins encouraged his audience to be passionate about their dreams, to explore and take risks, and to not be intimidated by people who tell them that something is impossible. Collins said, "Have fun doing the impossible!"

A prepared text of Dr. Collins' Commencement address is available on CEM's website at www.cem.com.

CEM Corporation, a private company based in Matthews, North Carolina, is the leading global company specializing in scientific solutions for critical laboratory applications. The Company has subsidiaries in the United Kingdom, Germany, Italy, France, and Japan, as well as a global network of distributors. CEM designs and manufactures systems for bioscience applications, life sciences, analytical laboratories and processing plants worldwide. The Company's products are used in many industries including pharmaceutical, biotech, chemical and food processing, as well as academic research.


'/>"/>
SOURCE CEM Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Darius Naigamwalla Appointed Senior Vice President and Head of the Brand Management Practice at Campbell Alliance
2. AEterna Zentaris Announces Appointment of Prof. Jurgen Engel, Ph.D. as New President and CEO
3. RainDance Technologies Appoints Olex Vice President, System Development
4. [video] David Brown, President and CEO of LifeVantage Corporation, Discusses Record Page Views on WallSt.nets 3-Minute Press Show
5. 4C Controls Announces the Appointment of Dr. Philip Hayden as Vice President, Security Assessment & Threat Analysis
6. Nicholas J. Hart Joins Emisphere as Vice President, Strategy and Development
7. Bill Pollock, President and CEO of Pharmagistics Group, Named to PharmaVOICE List of 100 Most Inspiring and Influential Leaders in the Life Sciences
8. US Oncology Appoints Stephen Smith Vice President/General Manager Research and Personalized Science Services
9. UltraShape Appoints Assaf Eyal as President & CEO
10. Micromet, Inc. Appoints Barclay Phillips as Senior Vice President and Chief Financial Officer
11. Anesiva Announces Appointment of William Houghton, M.D. as Senior Vice President and Chief Medical Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... ... a United States multicenter, prospective clinical study that demonstrates the accuracy of ... capable of identifying clinically significant acute bacterial and viral respiratory tract infections ...
(Date:10/11/2017)... , ... October 11, 2017 , ... ... gene in its endogenous context, enabling overexpression experiments and avoiding the use of ... small RNA guides is transformative for performing systematic gain-of-function studies. , This ...
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , Oct. 11, ... Research, London (ICR) and University of ... SkylineDx,s prognostic tool to risk-stratify patients with multiple myeloma (MM), ... nine . The University of Leeds ... funded by Myeloma UK, and ICR will perform the testing ...
(Date:10/10/2017)... , ... October 10, 2017 ... ... cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing ... HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in collaboration with Children’s ...
Breaking Biology Technology:
(Date:4/13/2017)... PUNE, India , April 13, 2017 According ... Identity Proofing, Identity Authentication, Identity Analytics, Identity Administration, and Authorization), Service, Authentication ... by MarketsandMarkets™, the IAM Market is expected to grow from USD 14.30 ... Annual Growth Rate (CAGR) of 17.3%. ... ...
(Date:4/11/2017)... , April 11, 2017 NXT-ID, Inc. ... technology company, announces the appointment of independent Directors Mr. ... to its Board of Directors, furthering the company,s corporate governance ... Gino ... we look forward to their guidance and benefiting from their ...
(Date:4/5/2017)... KEY FINDINGS The global market ... CAGR of 25.76% during the forecast period of 2017-2025. ... for the growth of the stem cell market. ... MARKET INSIGHTS The global stem cell market is segmented ... The stem cell market of the product is segmented ...
Breaking Biology News(10 mins):